Mayo Clinic Tapestry 2.0: Multi-Omics Health Discovery
Part of Genetic & congenital clinical trials.
This study uses advanced testing (called multi-omics) to look at your genes, proteins, and other molecules to discover new things about health and disease. You'll need to be a Mayo Clinic patient, able to receive packages, and not have a history of blood cancer or a donor bone marrow transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are a registered Mayo Clinic patient.
- You can give your written permission (informed consent) to join.
- You can receive mail and packages in a US state.
- You can collect and ship samples from a US state.
- You do not have an active blood cancer or a history of one.
- You have not had a donor bone marrow transplant (allogeneic).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to learn how to prevent blood cancers. You will provide samples over time so researchers can look for early signs of cancer.
This trial aims to improve how Mayo Clinic enrolls patients in research studies. If you join, you'll help researchers learn how to make trials run faster and more smoothly, which could benefit future patients.
This study collects blood, saliva, tumor tissue, or hair samples to look for inherited and tumor-related gene changes that may explain your cancer, guide prevention, or help find better treatments. You can join if you are a Mayo Clinic patient with cancer and your doctor has ordered genetic testing.
This study will collect blood samples from people who have had or are scheduled to have a multi-cancer detection test. Researchers want to learn more about how well these tests work and how the results affect follow-up care.
This study looks at cancer-related inherited gene changes using blood samples. It may help patients and doctors understand cancer risk and guide treatment planning, especially across different ethnic communities.
This study looks at real-world health outcomes and costs after whole-exome genetic testing done through the Tapestry program. Your results—whether they find something or not—are used to understand what happens next and how care decisions may change.
Hear when a new Genetic Predisposition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.